TCTMD
Etripamil Nasal Spray Gains FDA Approval for Acute Paroxysmal SVT
The self-administered treatment rapidly converts patients into sinus rhythm and may reduce trips to the hospital.
MedPage Today on MSN
Etripamil Gets FDA Approval for At-Home Tachycardia Conversion
The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), ...
Milestone Wins FDA Approval For First Self-Use Nasal Spray For Sudden Fast Heartbeats
The FDA approved Milestone Pharmaceuticals' Cardamyst nasal spray for acute episodes of PSVT in adults. First treatment for ...
Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (…
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly ...